Skip to main content

Articles

Page 3 of 15

  1. Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone tre...

    Authors: Kerry Marshall, Geoffrey Maina and Jordan Sherstobitoff
    Citation: Addiction Science & Clinical Practice 2021 16:42
  2. Opioid use disorder (OUD) disproportionately impacts rural and American Indian communities and has quadrupled among pregnant individuals nationwide in the past two decades. Yet, limited data are available abou...

    Authors: A. Taylor Kelley, Marcela C. Smid, Jacob D. Baylis, Elizabeth Charron, Amy E. Binns-Calvey, Shayla Archer, Saul J. Weiner, Lori Jo Begaye and Gerald Cochran
    Citation: Addiction Science & Clinical Practice 2021 16:40
  3. Because of the shortage of health professionals in Chilean primary care, Health Technicians (HT) are providing Brief Interventions (BI) for risky alcohol consumption. We compared the efficacy of two AUDIT-link...

    Authors: Nicolas A. Barticevic, Fernando Poblete, Soledad M. Zuzulich, Victoria Rodriguez, Diego Quevedo, Brena F. Sena and Laura Bradshaw
    Citation: Addiction Science & Clinical Practice 2021 16:39
  4. Measurement-based care (MBC) is the practice of routinely administering standardized measures to support clinical decision-making and monitor treatment progress. Despite evidence of its effectiveness, MBC is r...

    Authors: Justin S. Tauscher, Eliza B. Cohn, Tascha R. Johnson, Kaylie D. Diteman, Richard K. Ries, David C. Atkins and Kevin A. Hallgren
    Citation: Addiction Science & Clinical Practice 2021 16:38
  5. Most Americans with opioid use disorder (OUD) do not receive indicated medical care. A clinical decision support (CDS) tool for primary care providers (PCPs) could address this treatment gap. Our primary objec...

    Authors: Rebecca C. Rossom, JoAnn M. Sperl-Hillen, Patrick J. O’Connor, A. Lauren Crain, Laurel Nightingale, Anne Pylkas, Kristen V. Huntley and Gavin Bart
    Citation: Addiction Science & Clinical Practice 2021 16:37
  6. Opioid withdrawal symptoms prior to buprenorphine initiation may be intolerable and as a result, alternative strategies have emerged. We aim to systematically review the efficacy and safety of buprenorphine in...

    Authors: K. K. Adams, M. Machnicz and D. M. Sobieraj
    Citation: Addiction Science & Clinical Practice 2021 16:36
  7. Gambling-related harm is an increasing recognised problem internationally. Recent years have seen an explosion in opportunities to gamble, both in person and online. Health and other care settings have the pot...

    Authors: Lindsay Blank, Susan Baxter, Helen Buckley Woods and Elizabeth Goyder
    Citation: Addiction Science & Clinical Practice 2021 16:35
  8. Successfully combating the opioid crisis requires patients who misuse opioids to have access to affirming and effective health care. However, there is a shortage of physicians who are willing to work with thes...

    Authors: Berkeley Franz, Lindsay Y. Dhanani and Daniel L. Brook
    Citation: Addiction Science & Clinical Practice 2021 16:33
  9. Youth are frequently exposed to drugs, and most youth who misuse drugs are reluctant to seek help from services due to the worry of others being judgmental, lacking expertise, exposing their personal informati...

    Authors: William Ho Cheung Li, Wei Xia, Laurie Long Kwan Ho, Ankie Tan Cheung, Queenie Kuai I. Leong and Tingna Liang
    Citation: Addiction Science & Clinical Practice 2021 16:32
  10. Screening, brief intervention and referral to treatment (SBIRT) programmes have resulted in generally positive outcomes in healthcare settings, particularly for problem alcohol use, yet implementation is hampe...

    Authors: Claire van der Westhuizen, Megan Malan, Tracey Naledi, Marinda Roelofse, Bronwyn Myers, Dan J. Stein, Sa’ad Lahri and Katherine Sorsdahl
    Citation: Addiction Science & Clinical Practice 2021 16:31
  11. Homeless youth experience high rates of substance use disorders, exposures to violence, mental and physical health conditions, and mortality. They have been particularly affected by the opioid crisis. However,...

    Authors: Natasha Slesnick, Laura Chavez, Alicia Bunger, Ruri Famelia, Jodi Ford, Xin Feng, Sarah Higgins, Eugene Holowacz, Soren Jaderlund, Ellison Luthy, Allen Mallory, Jared Martin, Laura Walsh, Tansel Yilmazer and Kelly Kelleher
    Citation: Addiction Science & Clinical Practice 2021 16:30
  12. High comorbidity exists between mental illness and substance use disorders (SUD). Patients in psychiatry living with problematic alcohol or drug consumption can experience a sense of exclusion, where seeking h...

    Authors: Elisabeth Petersén, Anna Thurang and Anne H. Berman
    Citation: Addiction Science & Clinical Practice 2021 16:29
  13. Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a n...

    Authors: Betty Tai, Ronald Dobbins, Quandra Blackeney, David Liu and Landhing Moran
    Citation: Addiction Science & Clinical Practice 2021 16:28
  14. South Africa is marked by high rates of both HIV and alcohol use, and there is a detrimental synergistic relationship between these two epidemics. The Institute of Medicine recommends integrated care for alcoh...

    Authors: Caroline C. Kuo, Goodman Sibeko, Morayo Akande, Shaheema Allie, Nurain Tisaker, Dan J. Stein and Sara J. Becker
    Citation: Addiction Science & Clinical Practice 2021 16:27
  15. While patient-reported treatment dissatisfaction is considered an important factor in determining the success of substance use disorder treatment, the levels of dissatisfaction with opioid agonist therapies (O...

    Authors: Lindsay Mackay, Thomas Kerr, Nadia Fairbairn, Cameron Grant, M.-J. Milloy and Kanna Hayashi
    Citation: Addiction Science & Clinical Practice 2021 16:26
  16. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, Melissa B. Weimer and Zoe M. Weinstein
    Citation: Addiction Science & Clinical Practice 2021 16:25

    The original article was published in Addiction Science & Clinical Practice 2021 16:13

  17. Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities. With the immediate need for remote...

    Authors: Yih-Ing Hser, Allison J. Ober, Alex R. Dopp, Chunqing Lin, Katie P. Osterhage, Sarah E. Clingan, Larissa J. Mooney, Megan E. Curtis, Lisa A. Marsch, Bethany McLeman, Emily Hichborn, Laurie S. Lester, Laura-Mae Baldwin, Yanping Liu, Petra Jacobs and Andrew J. Saxon
    Citation: Addiction Science & Clinical Practice 2021 16:24
  18. Unhealthy alcohol use is a key concern for Aboriginal and Torres Strait Islander (‘Indigenous Australian’) communities. Due to systematic disadvantage and inter-generational trauma, Indigenous Australians may ...

    Authors: James H. Conigrave, Emma L. Bradshaw, Katherine M. Conigrave, Richard M. Ryan, Scott Wilson, Jimmy Perry, Michael F. Doyle and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2021 16:23
  19. Knowledge of medical conditions and their evidence-based medications varies among individuals. This range of knowledge may affect attitudes and influence medical decision-making of both patients and providers....

    Authors: Caroline Shadowen, Rachel Wheeler and Mishka Terplan
    Citation: Addiction Science & Clinical Practice 2021 16:22
  20. The Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) is commonly used in hospitals to titrate medications for alcohol withdrawal syndrome (AWS), but may be difficult to apply to intensive...

    Authors: Tessa L. Steel, Shewit P. Giovanni, Sarah C. Katsandres, Shawn M. Cohen, Kevin B. Stephenson, Ben Murray, Hillary Sobeck, Catherine L. Hough, Katharine A. Bradley and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2021 16:21
  21. Chronic pain and heavy drinking are conditions that commonly co-occur among primary care patients. Despite the availability of behavioral interventions that target these conditions individually, engagement and...

    Authors: Tibor P. Palfai, Maya P. L. Kratzer, Natalia E. Morone and Judith A. Bernstein
    Citation: Addiction Science & Clinical Practice 2021 16:20
  22. Opioid misuse screening in hospitals is resource-intensive and rarely done. Many hospitalized patients are never offered opioid treatment. An automated approach leveraging routinely captured electronic health ...

    Authors: Majid Afshar, Brihat Sharma, Sameer Bhalla, Hale M. Thompson, Dmitriy Dligach, Randy A. Boley, Ekta Kishen, Alan Simmons, Kathryn Perticone and Niranjan S. Karnik
    Citation: Addiction Science & Clinical Practice 2021 16:19
  23. Studies indicate high rates of substance use among youth experiencing homelessness (YEH). Further, the social networks of YEH, although multi-dimensional in composition, are largely comprised of other YEH, sub...

    Authors: Joan S. Tucker, David P. Kennedy, Karen Chan Osilla and Daniela Golinelli
    Citation: Addiction Science & Clinical Practice 2021 16:18
  24. Randomized trials of complex interventions are increasingly including qualitative components to further understand factors that contribute to their success. In this paper, we explore the experiences of health ...

    Authors: Nadia Minian, Aliya Noormohamed, Mathangee Lingam, Laurie Zawertailo, Bernard Le Foll, Jürgen Rehm, Norman Giesbrecht, Andriy V. Samokhvalov, Dolly Baliunas and Peter Selby
    Citation: Addiction Science & Clinical Practice 2021 16:17
  25. For many reasons, the emergency department (ED) is a critical venue to initiate OUD interventions. The prevailing culture of the ED has been that substance use disorders are non-emergent conditions better addr...

    Authors: Ryan P. McCormack, John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Liu, E. Jennifer Edelman, Sarah Farkas, Abigail G. Matthews, Caroline Mulatya, Dagmar Salazar, Jeremy Wolff, Randolph Knight, William Goodman…
    Citation: Addiction Science & Clinical Practice 2021 16:16
  26. Opioid use disorder continues to be a significant problem in the United States and worldwide. Three medications—methadone, buprenorphine, and extended-release injectable naltrexone,— are efficacious for treati...

    Authors: Matisyahu Shulman, Roger Weiss, John Rotrosen, Patricia Novo, Elizabeth Costello and Edward V. Nunes
    Citation: Addiction Science & Clinical Practice 2021 16:15
  27. We describe addiction consult services (ACS) adaptations implemented during the Novel Coronavirus Disease 2019 (COVID-19) pandemic across four different North American sites: St. Paul’s Hospital in Vancouver, ...

    Authors: Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, Melissa B. Weimer and Zoe M. Weinstein
    Citation: Addiction Science & Clinical Practice 2021 16:13

    The Correction to this article has been published in Addiction Science & Clinical Practice 2021 16:25

  28. The treatment capacity for opioid use disorder (OUD) lags far behind the number of patients in need of treatment. Capacity is limited, in part, by the limited number of physicians who offer office based OUD tr...

    Authors: Adriane M. dela Cruz, Robrina Walker, Ronny Pipes, Sidarth Wakhlu and Madhukar H. Trivedi
    Citation: Addiction Science & Clinical Practice 2021 16:12
  29. Buprenorphine/naloxone (Suboxone) is a current first-line treatment for opioid use disorder (OUD). The standard induction method of buprenorphine/naloxone requires patients to be abstinent from opioids and the...

    Authors: James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Y. C. Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew and Pouya Azar
    Citation: Addiction Science & Clinical Practice 2021 16:11
  30. Recently, electronic cigarette (e-cig) usage has increased significantly, making it a potentially effective smoking cessation tool. In Muslim countries, most people who use e-cigarettes fast the month of Ramad...

    Authors: Muna M. Barakat, Raja’a A. Al-Qudah, Ibrahim Alfayoumi, Hala Jehad Al-Obaidi, Feras Jassim Jirjees and Iman Basheti
    Citation: Addiction Science & Clinical Practice 2021 16:10
  31. Most people with opioid use disorder (OUD) never receive treatment. Medication treatment of OUD in primary care is recommended as an approach to increase access to care. The PRimary Care Opioid Use Disorders t...

    Authors: Cynthia I. Campbell, Andrew J. Saxon, Denise M. Boudreau, Paige D. Wartko, Jennifer F. Bobb, Amy K. Lee, Abigail G. Matthews, Jennifer McCormack, David S. Liu, Megan Addis, Andrea Altschuler, Jeffrey H. Samet, Colleen T. LaBelle, Julia Arnsten, Ryan M. Caldeiro, Douglas T. Borst…
    Citation: Addiction Science & Clinical Practice 2021 16:9
  32. Increasingly, treatment for opioid use disorder (OUD) is offered in integrated treatment models addressing both substance use and other health conditions within the same system. This often includes offering me...

    Authors: Elizabeth C. Saunders, Sarah K. Moore, Olivia Walsh, Stephen A. Metcalf, Alan J. Budney, Patricia Cavazos-Rehg, Emily Scherer and Lisa A. Marsch
    Citation: Addiction Science & Clinical Practice 2021 16:8
  33. Opioid use disorder (OUD) is a medical condition that has evolved into a serious and deadly epidemic in the United States. Both medical and psychological interventions are called for to end this growing epidem...

    Authors: Hunter M. Puckett, Jenny S. Bossaller and Lincoln R. Sheets
    Citation: Addiction Science & Clinical Practice 2021 16:6
  34. The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. The identification of risk groups is essential for the establishment of preventive and ther...

    Authors: Ellen Mello Borgonhi, Vanessa Loss Volpatto, Felipe Ornell, Francisco Diego Rabelo-da-Ponte and Felix Henrique Paim Kessler
    Citation: Addiction Science & Clinical Practice 2021 16:5
  35. The COVID-19 pandemic has resulted in unparalleled societal disruption with wide ranging effects on individual liberties, the economy, and physical and mental health. While no social strata or population has b...

    Authors: Ethan Cowan, Maria R. Khan, Siri Shastry and E. Jennifer Edelman
    Citation: Addiction Science & Clinical Practice 2021 16:4
  36. Effective brief treatments for methamphetamine use disorders (MAUD) are urgently needed to complement longer more intensive treatments in low and middle income countries, including South Africa. To address thi...

    Authors: K. Sorsdahl, D. J. Stein, S. Pasche, Y. Jacobs, R. Kader, B. Odlaug, S. Richter, B. Myers and J. E. Grant
    Citation: Addiction Science & Clinical Practice 2021 16:3
  37. Mutual support groups are a popular treatment for substance use and other addictive behaviours. However, little is known about the cultural utility of these programmes for Indigenous peoples.

    Authors: Elizabeth Dale, Katherine M. Conigrave, Peter J. Kelly, Rowena Ivers, Kathleen Clapham and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2021 16:2
  38. Describe methods to compile a unified database from disparate state agency datasets linking person-level data on controlled substance prescribing, overdose, and treatment for opioid use disorder in Connecticut.

    Authors: William C. Becker, Robert Heimer, Catherine M. Dormitzer, Molly Doernberg, Gail D’Onofrio, Lauretta E. Grau, Kathryn Hawk, Hsiu-Ju Lin, Alex M. Secora and David A. Fiellin
    Citation: Addiction Science & Clinical Practice 2021 16:1
  39. Opioid use disorder (OUD) among women delivering at a hospital has increased 400% from 1999–2014 in the United States. From the years 2007 to 2016, opioid-related mortality during pregnancy increased over 200%...

    Authors: M. Aryana Bryan, Marcela C. Smid, Melissa Cheng, Katherine T. Fortenberry, Amy Kenney, Bhanu Muniyappa, Danielle Pendergrass, Adam J. Gordon and Gerald Cochran
    Citation: Addiction Science & Clinical Practice 2020 15:33
  40. Alcohol affects Indigenous communities globally that have been colonised. These effects are physical, psychological, financial and cultural. This systematic review aims to describe the prevalence of current (1...

    Authors: Teagan J. Weatherall, Katherine M. Conigrave, James H. Conigrave and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2020 15:32
  41. First Nations peoples of Australia, New Zealand, the United States of America (USA) and Canada are more likely to be non-drinkers than other people in these countries. However, those who do drink may be at gre...

    Authors: Gemma C. Purcell-Khodr, K. S. Kylie Lee, James H. Conigrave, Emma Webster and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2020 15:31
  42. Office-based buprenorphine treatment of opioid use disorder (OUD) does not typically include in-person directly observed therapy (DOT), potentially leading to non-adherence. Video DOT technologies may safeguar...

    Authors: Zachery A. Schramm, Brian G. Leroux, Andrea C. Radick, Alicia S. Ventura, Jared W. Klein, Jeffrey H. Samet, Andrew J. Saxon, Theresa W. Kim and Judith I. Tsui
    Citation: Addiction Science & Clinical Practice 2020 15:30
  43. Integrating behavioral health in primary care is a widespread endeavor. Yet rampant variation exists in models and approaches. One significant question is whether frontline providers perceive that behavioral h...

    Authors: Ida Q. Chen, Helene Chokron Garneau, Timothy Seay-Morrison, Megan R. Mahoney, Heather Filipowicz and Mark P. McGovern
    Citation: Addiction Science & Clinical Practice 2020 15:29
  44. At-risk levels of alcohol use threaten the health of patients with HIV (PWH), yet evidence-based strategies to decrease alcohol use and improve HIV-related outcomes in this population are lacking. We examined ...

    Authors: E. Jennifer Edelman, Stephen A. Maisto, Nathan B. Hansen, Christopher J. Cutter, James Dziura, Yanhong Deng, Lynn E. Fiellin, Patrick G. O’Connor, Roger Bedimo, Cynthia L. Gibert, Vincent C. Marconi, David Rimland, Maria C. Rodriguez-Barradas, Michael S. Simberkoff, Janet P. Tate, Amy C. Justice…
    Citation: Addiction Science & Clinical Practice 2020 15:28
  45. Aboriginal alcohol and other drug residential rehabilitation (residential rehabilitation) services have been providing treatment in Australia of over 50 years. However, there are no studies in Australia or int...

    Authors: Douglas B. James, KS Kylie Lee, Tania Patrao, Ryan J. Courtney, Katherine M. Conigrave and Anthony Shakeshaft
    Citation: Addiction Science & Clinical Practice 2020 15:27

Affiliated with

Annual Journal Metrics

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.